Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

[ad_1] MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement with Denmark-based WIIK Pharma ApS (Wiik Pharma)…

Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study

[ad_1] MELBOURNE, Australia, May 7, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to…